MobiHealth News July 2, 2020
MobiHealthNews

Despite the uncertainty of COVID-19, funding deals during the last three months were generally on par with those of Q1 2020 and Q2 2019.

As the broader economy ping pongs between state lockdowns, unemployment reports and escalating public markets, COVID-19 still down’t appear to have torpedoed investors’ interests in digital health.

During the second quarter of 2020, MobiHealthNews tracked 89 funding deals totaling $2.44 billion – a slight increase in volume but decline in value when compared to both Q2 2019 (81 deals, $2.45 billion) and Q1 2020 (82 deals, $2.9 billion). That broader spread of funds isn’t to say that there weren’t some heavy-hitting deals this quarter, as startups focused on insurtech, telehealth, artificial intelligence drug discovery, and tech-enabled...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends
Embracing digital transformation with a digital factory
Why Should Payers Spend Money on Digital Diabetes Solutions?
How Remote Patient Monitoring and AI Personalize Care
Digital Platforms Streamline Medication Access and Delivery
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say

Share This Article